|
|
Decoding Selective Vulnerability: Effectors and Regulators of Tau Lesion Spread in Alzheimers Disease |
| 1F30AG072804-01A1 |
|
NIA |
2022 |
|
|
Behavioral, molecular, and functional dissection of corticospinal neurons in motor performance deficits of physiological and pathological aging |
| 1F30AG074598-01A1 |
|
NIA |
2022 |
|
|
Development of a Novel PET Tracer for Imaging Microglial Function in Alzheimers Disease |
| 1F30AG074633-01A1 |
|
NIA |
2022 |
|
|
The role of mitochondrial fission in neurodegeneration in the leading environmental cause of Alzheimers disease |
| 1F30AG076183-01A1 |
|
NIA |
2022 |
|
|
Uncharted Territory: Mapping and Manipulating Cholinergic Basal Forebrain Activity in a Mouse Model of Alzheimers Disease |
| 1F30AG076265-01A1 |
|
NIA |
2022 |
|
|
Treatment of Alzheimer’s Disease using Ultrasound-Targeted Microbubble Cavitation-Mediated Blood Brain Barrier Opening to Facilitate Drug Delivery to the Brain |
| 1F30AG077800-01 |
|
NIA |
2022 |
|
|
Neurophysiological Basis for Functional Connectivity Changes in Early Alzheimer’s Disease |
| 1F30AG079507-01 |
|
NIA |
2022 |
|
|
The gut microbiome in Alzheimers disease: exploring the role of astrocytes |
| 1F30AG079577-01 |
|
NIA |
2022 |
|
|
APOE4 Increases Astrocytic Tau Internalization to Promote Alzheimer’s-Related Neuronal Pathology |
| 1F31AG071131-01A1 |
|
NIA |
2022 |
|
|
Apolipoprotein E and immunometabolism in Alzheimers disease |
| 1F31AG076282-01 |
|
NIA |
2022 |
